(Q68896117)
Statements
IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2 (English)
Slavin S
Ackerstein A
Kedar E
scientific article published on 01 July 1990